Asian Spectator


The Times

.

Josh Ferris and Justine Guerard Triumph at the 32nd Laguna Phuket Triathlon, Asia’s Longest-Running Triathlon

Australia’s Ferris and France’s Guerard conquer Phuket’s iconic resort racecourse, as international athletes battle for USD 20,000 in prize money.PHUKET, THAILAND – Media OutR...

89 Local Companies Recognised as Consumer Caring Companies by GS1 Hong Kong

Retail & Food Companies Attract New Consumers with Consumer-first Strategies as HK Returns to NormalcyHONG KONG SAR - Media OutReach - 13 April 2023 - With the full resumption of econom...

Sangfor Technologies Leads Next-Generation VMware Alternatives Conversation at Executive Forum 2026 in Bangkok

BANGKOK, THAILAND - Media OutReach Newswire - 18 May 2026 - Sangfor Technologies successfully hosted the Sangfor Executive Forum 2026 in Bangkok, bringing together CIOs, IT leaders, and cyb...

Aucnet Establishes Sustainability Policy to Promote Its Adopti...

TOKYO, Sep. 10, 2021 /Kyodo JBN-AsiaNet/ -- - Aiming to Contribute to Sustainable Society by Realizing Circular Distribution on Global Scale -Aucnet Inc. (hereinafter "Aucnet"), headquartere...

REALTY ONE GROUP AGAIN NAMED REAL ESTATE'S ONLY FAST SERIOUS...

LAS VEGAS, Jan. 19, 2022 /PRNewswire-AsiaNet/ -- Realty ONE Group, a modern, purpose-driven lifestyle brand and ONE of the fastest growing franchisors in the world, was named again real esta...

Samson Paper Announces FY18/19 Annual Results

Profit Attributable to the Owners of the Company (without fair value gain) Rises 46.1%;Trading Business Becomes the Group's Growth EngineHONG KONG, Jun 18, 2019 - (ACN Newswire) - Samson Pa...

Handheld introduces new wearable RS60 Ring Scanner

LIDKOPING, Sweden, Aug. 26, 2021 /PRNewswire-AsiaNet/ -- Handheld Group,[ https://www.handheldgroup.com/?utm_source=PRNewsWire&utm_medium=PressRelease&utm_campaign=RS60Launch ] a lea...

The Gifted Music Creator Kurt Hugo Schneider Crafted A Million...

TAIPEI, Nov. 3, 2021 /PRNewswire-AsiaNet/ -- Widely known for his originals and creative covers, along with his extraordinary performance of pop music hits, the talented singer-songwriter Ku...

Petra Rumpf Appointed As New Limacorporate Advisory Board Member

UDINE, Italy, October 21, 2020, /PRNewswire-AsiaNet/-- LimaCorporate is pleased to announce that Petra Rumpf has joined the LimaCorporate Advisory Board starting September 22, 2020.Petra Rum...

Eisai to Present New Research on Eribulin (Halaven) at 42nd Annual San Antonio Breast Cancer Symposium

Eisai to Present New Research on Eribulin (Halaven) at 42nd Annual San Antonio Breast Cancer Symposium

TOKYO, Dec 5, 2019 - (JCN Newswire) - Eisai Co., Ltd. announced today that the latest information on its in-house discovered and developed eribulin mesylate (halichondrin class microtubule dynamics inhibitor, product name: HALAVEN, "eribulin") will be presented during the 42nd San Antonio Breast Cancer Symposium (SABCS2019). The symposium will be held from December 10 through 14, 2019, in San Antonio, Texas in the United States.

Eisai to Present New Research on Eribulin (Halaven) at 42nd Annual San Antonio Breast Cancer Symposium

A total of five poster presentations will be given at this year's SABCS including the study results evaluating absolute lymphocyte count at the baseline with eribulin as a predictor of overall survival from the post-hoc analysis of two Phase III clinical studies of eribulin in patients with advanced or metastatic breast cancer.Eisai positions oncology as a key therapeutic area, and is aiming to discover revolutionary new medicines with the potential to cure cancer. Eisai will continue to create innovation in the development of new drugs based on cutting-edge cancer research, as it seeks to contribute further to addressing the diverse needs of, and increasing the benefits provided to, patients with cancer, their families, and healthcare providers.

About Eisai

Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. We define our corporate mission as "giving first thought to patients and their families and to increasing the benefits health care provides," which we call our human health care (hhc) philosophy. With approximately 10,000 employees working across our global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to realize our hhc philosophy by delivering innovative products in various therapeutic areas with high unmet medical needs, including Neurology and Oncology.

In its medium-term business plan EWAY2025, Eisai is aiming to become a "Medico Societal Innovator" (a company that changes society through creating medicines and providing solutions), and is working on establishment of ecosystem platform business utilizing various data such as a large amount of clinical data, experiences, and know-how.

For more information about Eisai Co., Ltd., please visit https://www.eisai.co.jp.

Contact:Public Relations Department,
Eisai Co., Ltd.
+81-(0)3-3817-5120

Copyright 2019 JCN Newswire. All rights reserved. www.jcnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

What to Consider Before Choosing a Cardboard Box Manufacturer

Start With the Packaging Purpose The right packaging begins with a clear understanding of what the box needs to do. A cardboard box manufacturer can help translate requirements such as product prot...

Why Emotional Battles Drain Your Wealth During Separation

Navigating a marriage ending is fundamentally a structural transition, not just an emotional event. When you approach separation with a clear roadmap, you protect your long term financial stability ...

How Long Does Botox Really Last? A Realistic Timeline

Someone might notice a line between their eyebrows getting deeper after a stressful week, or catch their forehead creasing in a video call in a way it did not before. It is a small observation, easy...

hacklink esim senegalmarsbahisuk casinos not on gamstophttps://www.capitolcitycinema.org/grandpashabet resmi girişStreamEastStreamEastjojobet